Infliximab in steroid-resistant ulcerative colitis: A randomised controlled trial

被引:0
|
作者
Probert, CSJ
Hearing, SD
Schreiber, S
Kuhbacher, T
Ghosh, S
Forbes, A
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
772
引用
收藏
页码:A99 / A99
页数:1
相关论文
共 50 条
  • [21] Neoral may be as effective as intravenous cyclosporine in the treatment of steroid-resistant ulcerative colitis
    Oppong, K
    Record, CO
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (07): : 1188 - 1189
  • [22] PREDICT UC: Optimising Infliximab Induction therapy for Acute Severe Ulcerative Colitis - A Randomised Controlled Trial
    Choy, M.
    Suen, C. F. D. Li Wai
    Con, D.
    Boyd, K.
    Pena, R.
    Burrell, K.
    Rosella, O.
    Proud, D.
    Brouwer, R.
    Gorelik, A.
    Liew, D.
    Connell, W.
    Wright, E.
    Taylor, K.
    Pudipeddi, A.
    Sawers, M.
    Christensen, B.
    Ng, W.
    Begun, J.
    Radford-Smith, G.
    Garg, M.
    Martin, N.
    Van Langenberg, D. R.
    Ding, N. S.
    Beswick, L.
    Leong, R. W.
    Sparrow, M. P.
    De Cruz, P.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1600 - I1600
  • [23] Infliximab in Steroid-Dependent Ulcerative Colitis
    Armuzzi, Alessandro
    Pugliese, Daniela
    Marzo, Manuela
    Felice, Carla
    Andrisani, Gianluca
    Vitale, Giovanna
    Mocci, Giammarco
    De Vitis, Italo
    Papa, Alfredo
    Rapaccini, Gian Ludovico
    Guidi, Luisa
    GASTROENTEROLOGY, 2011, 140 (05) : S592 - S592
  • [24] INFLIXIMAB IN STEROID-DEPENDENT ULCERATIVE COLITIS
    Armuzzi, A.
    Pugliese, D.
    Marzo, M.
    Felice, C.
    Andrisani, G.
    De Vincentis, F.
    Mocci, G.
    De Vitis, I.
    Papa, A.
    Rapaccini, G. L.
    Guidi, L.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S133 - S133
  • [25] Infliximab in patients with steroid refractory ulcerative Colitis
    Boecker, U.
    GASTROENTEROLOGE, 2006, 1 (04): : 289 - 290
  • [26] Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis (vol 25, pg 330, 1997)
    Ardizzone, S
    Molteni, P
    Imbesi, V
    Bollani, S
    Porro, GB
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 1998, 26 (03) : 231 - 231
  • [27] Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease
    Creed, TJ
    Probert, CSJ
    Norman, MN
    Moorghen, M
    Shepherd, NA
    Hearing, SD
    Dayan, CM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 23 (10) : 1435 - 1442
  • [28] Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
    Ardizzone, S
    Maconi, G
    Russo, A
    Imbesi, V
    Colombo, E
    Porro, GB
    GUT, 2006, 55 (01) : 47 - 53
  • [29] Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
    Kobayashi, Taku
    Motoya, Satoshi
    Nakamura, Shiro
    Yamamoto, Takayuki
    Nagahori, Masakazu
    Tanaka, Shinji
    Hisamatsu, Tadakazu
    Hirai, Fumihito
    Nakase, Hiroshi
    Watanabe, Kenji
    Matsumoto, Takayuki
    Tanaka, Masanori
    Abe, Takayuki
    Suzuki, Yasuo
    Watanabe, Mamoru
    Hibi, Toshifumi
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (06): : 429 - 437
  • [30] Faecal microbiota transplantation in Ulcerative Colitis: A randomised controlled trial
    Rossen, N.
    Fuentes, S.
    van der Spek, M.
    Tijssen, J.
    Hartman, J.
    Duflou, A.
    Mathus-Vliegen, L.
    de Vos, W.
    Zoetendal, E.
    D'haens, G.
    Ponsioen, C.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S2 - S2